Literature DB >> 22349663

Percutaneous recanalization of an occluded hepatic vein in a difficult subset of pediatric Budd-Chiari syndrome.

Maitri Chaudhuri1, Mahimarangaiah Jayaranganath, Vidhyashankar Subash Chandra.   

Abstract

We present a 3-year-old child with Budd Chiari syndrome having idiopathic complete occlusion of all three major hepatic veins and small hepatic venules. Adequate antegrade flow in right hepatic vein was established by transfemoral balloon angioplasty followed by stenting of the same. Long term antiplatelet therapy was instituted. Medium term follow up reveals satisfactory antegrade flow and regression of symptoms. This strategy highlights an effective nonsurgical approach of restoring physiological pattern of hepatic sinusoidal blood flow in Budd Chiari syndrome.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22349663     DOI: 10.1007/s00246-012-0188-9

Source DB:  PubMed          Journal:  Pediatr Cardiol        ISSN: 0172-0643            Impact factor:   1.655


  16 in total

Review 1.  Budd-Chiari syndrome: a review by an expert panel.

Authors:  Harry L A Janssen; Juan-Carlos Garcia-Pagan; Elwyn Elias; Gilles Mentha; Antoine Hadengue; Dominique-Charles Valla
Journal:  J Hepatol       Date:  2003-03       Impact factor: 25.083

2.  Cause of portal or hepatic venous thrombosis in adults: the role of multiple concurrent factors.

Authors:  M H Denninger; Y Chaït; N Casadevall; S Hillaire; M C Guillin; A Bezeaud; S Erlinger; J Briere; D Valla
Journal:  Hepatology       Date:  2000-03       Impact factor: 17.425

3.  Favourable medium term outcome following hepatic vein recanalisation and/or transjugular intrahepatic portosystemic shunt for Budd Chiari syndrome.

Authors:  C E Eapen; D Velissaris; M Heydtmann; B Gunson; S Olliff; E Elias
Journal:  Gut       Date:  2005-09-20       Impact factor: 23.059

4.  Evolving consensus in portal hypertension. Report of the Baveno IV consensus workshop on methodology of diagnosis and therapy in portal hypertension.

Authors:  Roberto de Franchis
Journal:  J Hepatol       Date:  2005-07       Impact factor: 25.083

Review 5.  Changing profile of Budd Chiari syndrome in India.

Authors:  C E Eapen; Thomas Mammen; Vinu Moses; N K Shyamkumar
Journal:  Indian J Gastroenterol       Date:  2007 Mar-Apr

6.  Factor V Leiden related Budd-Chiari syndrome.

Authors:  P Deltenre; M H Denninger; S Hillaire; M C Guillin; N Casadevall; J Brière; S Erlinger; D C Valla
Journal:  Gut       Date:  2001-02       Impact factor: 23.059

7.  Factor V Leiden mutation, prothrombin gene mutation, and deficiencies in coagulation inhibitors associated with Budd-Chiari syndrome and portal vein thrombosis: results of a case-control study.

Authors:  H L Janssen; J R Meinardi; F P Vleggaar; S H van Uum; E B Haagsma; F J van Der Meer; J van Hattum; R A Chamuleau; R P Adang; J P Vandenbroucke; B van Hoek; F R Rosendaal
Journal:  Blood       Date:  2000-10-01       Impact factor: 22.113

8.  Managing Budd-Chiari syndrome: a retrospective review of percutaneous hepatic vein angioplasty and surgical shunting.

Authors:  N C Fisher; I McCafferty; M Dolapci; M Wali; J A Buckels; S P Olliff; E Elias
Journal:  Gut       Date:  1999-04       Impact factor: 23.059

9.  Long-term effect of stent placement in 115 patients with Budd-Chiari syndrome.

Authors:  Chun-Qing Zhang; Li-Na Fu; Lin Xu; Guo-Quan Zhang; Tao Jia; Ji-Yong Liu; Cheng-Yong Qin; Ju-Ren Zhu
Journal:  World J Gastroenterol       Date:  2003-11       Impact factor: 5.742

Review 10.  Primary Budd-Chiari syndrome.

Authors:  Dominique-Charles Valla
Journal:  J Hepatol       Date:  2008-10-26       Impact factor: 25.083

View more
  1 in total

1.  FunMod: a Cytoscape plugin for identifying functional modules in undirected protein-protein networks.

Authors:  Massimo Natale; Alfredo Benso; Stefano Di Carlo; Elisa Ficarra
Journal:  Genomics Proteomics Bioinformatics       Date:  2014-08-19       Impact factor: 7.691

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.